CRISPR Technology: Transforming Global Markets and Our Future
"CRISPR is a gene-editing tool that makes precise DNA changes, advancing drug development, crop improvement, and disease research. It opens new business opportunities and offers solutions for genetic diseases and sustainable agriculture."
BOSTON, Jan. 2, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029 at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
This report on CRISPR technology offers market predictions through 2029, examining how CRISPR is used across different fields like drug development, agriculture and diagnostics. It also looks at the users of CRISPR, including biotech and pharmaceutical companies, universities, government research institutes, and contract research organizations.
Interesting facts:
- With Casegvy's approval in late 2023, the CRISPR market is set to grow, particularly in drug development for genetic and chronic diseases. Biotech and pharma companies are driving this growth, supported by collaborations and rising private funding for innovation and expanded CRISPR use.
Factors contributing to the market's growth include:
Request a Sample Copy of the CRISPR Technology: Global Markets Reports
Report Synopsis
Report Metric | Details |
Base year considered | 2023 |
Forecast period considered | 2024-2029 |
Base year market size | $3.4 billion |
Market size forecast | $7.5 billion |
Growth rate | CAGR of 14.4% from 2024 to 2029 |
Segments covered | Application, End User, and Region |
Regions covered | North America, Europe, Asia-Pacific and |
Countries covered | U.S., Canada, Germany, United Kingdom, |
Market drivers |
|
This report addresses the following key questions:
The global CRISPR technology market is expected to grow at a compound annual growth rate (CAGR) of 14.4% to reach $7.5 billion by the end of 2029, up from $3.8 billion in 2024.
These Include the rising incidence of chronic diseases, the high prevalence of genetic disorders, and growing government and private funding.
The CRISPR technology market is segmented based on application, end user, and region.
The drug development segment will dominate the market in 2029.
North America holds the highest share of the market.
Leading companies in the market include:
- Agilent Technologies Inc.
- Beam Therapeutics
- Caribou Biosciences Inc.
- Crispr Therapeutics
- Danaher Corp.
- Editas Medicine
- Genscript
- Intellia Therapeutics Inc.
- Lonza
- Merck KGaA
- Thermo Fisher Scientific Inc.
Related reports include:
Induced Pluripotent Stem Cells: Induced pluripotent stem cells (iPSCs) are adult cells reprogrammed to act like embryonic stem cells. They can develop into any cell type, making them useful for research, drug testing, and disease treatments, without the ethical issues of using embryonic cells.
Directly Purchase a copy of the report from BCC Research.
For further information on these reports or to purchase one, please get contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo - https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/crispr-technology-transforming-global-markets-and-our-future-302341473.html
SOURCE BCC Research LLC